Built at the Internet Archive
Creator
Sort By:
Publisher
Sort By:
Date
Sort By:
Sites for this collection are listed below. Narrow your results at left, or enter a search query below to find a site, specific URL or to search the text of archived webpages.
Page 1 of 1 (19 Total Results)
Sort By:
Description: Nine drug company CEO’s including Johnson & Johnson’s Alex Gorsky signed a September 8 pledge to continue making the safety of vaccinated individuals the top priority as they develop the first COVID-19 vaccines.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID-19, Johnson & Johnson , Vaccines
Creator: David Schatz
Publisher: New Brunswick Today
Source: www.newbrunswicktoday.com
Language: English
Coverage: New Brunswick, NJ
Format: article
Type: online newspaper
Date: September 13, 2020
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Description: Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, a Biden administration official confirmed Tuesday.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID-19, Johnson & Johnson , vaccines, Government, Merck & Co.
Creator: Associated Press
Publisher: News 12 NJ
Source: www.newjersey.news12.com
Language: English
Coverage: New Jersey
Format: online newspaper
Type: article
Date: March 2, 2021
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Description: The U.S. Food and Drug Administration will meet this Friday to decide whether or not to give emergency-use authorization to Johnson & Johnson's Covid-19 vaccine, according to the U.S. pharmaceutical giant.
Loading Wayback Capture Info...
Loading video data...
Subject: Johnson & Johnson , COVID-19, Vaccines, Government, Food and Drug Administration
Creator: Carly Baldwin
Publisher: Patch
Source: www.patch.com
Language: English
Coverage: New Brunswick, NJ
Format: online newspaper
Type: article
Date: February 23, 2021
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Description: Johnson & Johnson announced Wednesday that the company is launching the third, and final stage, of test trials for its coronavirus vaccine. And it's a possible cure that would require one shot instead of two.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID-19, Health, Vaccines, Johnson & Johnson
Creator: Carly Baldwin
Publisher: Patch
Source: www.patch.com
Language: English
Coverage: New Brunswick, NJ
Format: article
Type: online newspaper
Date: September 23, 2020
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Description: Big jumps in sales of prescription drugs and medical devices helped Johnson & Johnson boost its first-quarter profit nearly 7%, blowing past Wall Street forecasts.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID-19, vaccine, healthcare, Johnson & Johnson
Creator: Steven Senne
Publisher: The Brunswick News
Source: thebrunswicknews.com
Language: English
Coverage: New Brunswick, NJ
Format: article
Type: online newspaper
Date: April 20, 2021
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Description: Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older.
Loading Wayback Capture Info...
Loading video data...
Subject: Johnson & Johnson , COVID-19, Vaccines, Food and Drug Administration
Creator: Johnson & Johnson
Publisher: Johnson & Johnson
Source: www.jnj.com
Language: English
Format: website
Type: article
Date: February 27, 2021
Rights: http://rightsstatements.org/vocab/InC/1.0/
Collector: New Brunswick Free Public Library
Description: U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Loading Wayback Capture Info...
Loading video data...
Subject: Food and Drug Administration, Johnson & Johnson , Covid Vaccines, Health & Safety, Blood clots, Federal Government
Creator: Matthew Perrone, Lauren Neergaard
Publisher: Los Angeles Times
Source: www.latimes.com
Language: English
Format: online newspaper
Type: article
Date: May 5, 2022
Rights: http://rightsstatements.org/vocab/InC/1.0/
Collector: New Brunswick Free Public Library
Description: Johnson & Johnson (NYSE: JNJ) (the Company) today announced the completion of a landmark agreement between Janssen Pharmaceuticals, Inc., and manufacturer Aspen SA Operations (Pty) Ltd, based in South Africa, to enable the first COVID-19 vaccine to be manufactured and made available by an African company for people living in Africa, with the goal of increasing COVID-19 vaccination rates across the continent.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID, Johnson & Johnson , Vaccine, Africa
Creator: Johnson & Johnson
Publisher: News Journal
Source: www.news-journal.com
Language: English
Format: online newspaper
Type: article
Date: March 8, 2022
Rights: http://rightsstatements.org/vocab/InC/1.0/
Collector: New Brunswick Free Public Library
Description: Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID, Vaccines, Johnson & Johnson , Booster
Creator: Associated Press
Publisher: nj.com
Language: English
Coverage: New Jersey
Type: article
Date: October 5, 2021
Rights: http://rightsstatements.org/vocab/InC/1.0/
Collector: New Brunswick Free Public Library
Description: The Centers for Disease Control and Prevention’s vaccine advisory panel is expected to meet Thursday to consider potential restrictions on the vaccine after women have formed blood clots.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID, Johnson & Johnson , Health, Vaccines, Blood Clots
Creator: Spencer Kent
Publisher: www.nj.com
Source: www.nj.com
Language: English
Coverage: New Jersey
Format: online newspaper
Type: article
Date: December 16, 2021
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Description: Johnson & Johnson temporarily suspended production of its COVID-19 vaccine at an important plant in Holland, causing concern in some countries reliant on the single-dose shot.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID, Vaccines, Johnson & Johnson
Creator: Spencer Kent
Publisher: NJ.com
Source: www.NJ.com
Language: English
Coverage: New Jersey
Format: online newspaper
Type: article
Date: February 8, 2022
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Description: Americans who received the Johnson & Johnson coronavirus vaccine are less protected against serious illness and hospitalization and should get an mRNA booster, the CDC found in a new study.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID, Johnson & Johnson , Vaccines, Centers for Disease Control
Creator: Spencer Kent
Publisher: NJ.com
Source: www.nj.com
Language: English
Coverage: New Jersey
Format: online newspaper
Type: article
Date: March 31, 2022
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Description: Johnson & Johnson has begun shipping nearly 4 million doses of its newly authorized COVID-19 vaccine across the U.S., officials said Monday, and is expected to further scale up supply in the coming weeks and months.
Loading Wayback Capture Info...
Loading video data...
Subject: Johnson & Johnson , COVID-19, Vaccines
Creator: Rachel Treisman
Publisher: NPR
Source: www.npr.org
Language: English
Format: online newspaper
Type: article
Date: March 1, 2021
Rights: http://rightsstatements.org/vocab/InC/1.0/
Collector: New Brunswick Free Public Library
Description: Federal health officials called for a halt in the use of the company’s coronavirus vaccine while they study serious illnesses that developed in six American women.
Loading Wayback Capture Info...
Loading video data...
Subject: Johnson & Johnson , Vaccine, COVID-19, health
Creator: Noah Weiland, Sharon LaFraniere, Carl Zimmer
Publisher: New York Times
Source: www.nytimes.com
Language: English
Format: article
Type: Online newspaper
Date: April 13, 2021
Rights: http://rightsstatements.org/vocab/InC/1.0/
Collector: New Brunswick Free Public Library
Description: Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on behalf of the European Union (EU) Member States, has approved an Advance Purchase Agreement in which the Janssen Pharmaceutical Companies will supply 200 million doses of its COVID-19 vaccine candidate to EU Member States following approval or authorization from regulators.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID-19, Vaccines, Johnson & Johnson
Creator: Johnson & Johnson
Publisher: PRnewswire.com
Source: www.prnewswire.com
Language: English
Coverage: New Brunswick, NJ
Format: online newspaper
Type: article
Date: October 8, 2020
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Description: The study of Johnson & Johnson’s Covid-19 vaccine has been paused due to an unexplained illness in a study participant.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID-19, Johnson & Johnson , Vaccines, Health
Creator: Matthew Herper
Publisher: Statnews.com
Source: www.statnews.com
Language: English
Coverage: New Brunswick, NJ
Format: Online newspaper
Type: article
Date: October 12, 2020
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Description: Two major studies of vaccines against Covid-19, both paused because of potential safety concerns, are set to restart, the companies running them said Friday.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID-19, Vaccines, Health, Johnson & Johnson
Creator: Mathew Herper
Publisher: Statnews.com
Source: www.statnews.com
Language: English
Format: Online newspaper
Type: article
Date: October 23, 2020
Rights: http://rightsstatements.org/vocab/InC/1.0/
Collector: New Brunswick Free Public Library
Description: Rutgers will enroll as many as 2,000 participants from the university community and throughout the state to test a potential COVID-19 vaccine.
Loading Wayback Capture Info...
Loading video data...
Subject: Johnson & Johnson , Vaccines, Public Health, COVID-19, Rutgers
Creator: TAPINTONEWBRUNSWICK
Publisher: TapIntoNewBrunswick
Source: www.tapinto.net
Language: English
Coverage: New Brunswick, NJ
Format: online newspaper
Type: article
Date: November 17, 2020
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Description: A two-dose version of Johnson & Johnson’s coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday — making a two-dose regimen of J&J’s Janssen vaccine comparable to a two-dose regimen of Moderna’s or Pfizer’s.
Loading Wayback Capture Info...
Loading video data...
Subject: Johnson & Johnson , vaccines, COVID, Public Health
Creator: CNN
Publisher: 93.1 FM WIBC Radio
Source: https://www.wibc.com
Language: English
Format: website
Type: article
Date: September 21, 2021
Collector: New Brunswick Free Public Library
Contributor: CNN
Rights: http://rightsstatements.org/vocab/InC/1.0/
Page 1 of 1 (19 Total Results)
